Can-Fite BioPharma shared research showing that piclidenoson greatly lowers a kidney disease marker linked to Lowe syndrome.

CANF · Can-Fite BioPharma

The AI's read

This gives piclidenoson a possible role in a rare disorder with no curative treatment. The evidence comes from cells and animal models, so it does not show that patients will improve. Still, the reported changes support a favorable view of Can-Fite.